アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

zo skin health, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 20 mg in 1 ml - acne treatment - for the management of acne. - penetrates pores to control acne blemishes.

イスラエル - 英語 - Ministry of Health

padagis israel agencies ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 250 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.

イスラエル - 英語 - Ministry of Health

padagis israel agencies ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 500 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.

イスラエル - 英語 - Ministry of Health

padagis israel agencies ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 1000 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.

シンガポール - 英語 - HSA (Health Sciences Authority)

pfizer private limited - moroctocog alfa (af-cc) - injection, powder, for solution - 1000iu/vial - moroctocog alfa (af-cc) 1000iu/vial

シンガポール - 英語 - HSA (Health Sciences Authority)

pfizer private limited - moroctocog alfa (af-cc) - injection, powder, for solution - 2000iu/vial - moroctocog alfa (af-cc) 2000iu/vial

シンガポール - 英語 - HSA (Health Sciences Authority)

pfizer private limited - moroctocog alfa (af-cc) - injection, powder, for solution - 250iu/vial - moroctocog alfa (af-cc) 250iu/vial

シンガポール - 英語 - HSA (Health Sciences Authority)

pfizer private limited - moroctocog alfa (af-cc) - injection, powder, for solution - 500iu/vial - moroctocog alfa (af-cc) 500iu/vial

シンガポール - 英語 - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - antihemophilic factor (recombinant) - injection, powder, for solution - 1000 iu/vial - antihemophilic factor (recombinant) 1000 iu/vial

シンガポール - 英語 - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - antihemophilic factor (recombinant); antihemophilic factor (recombinant) - injection, powder, for solution - 250 iu/vial - antihemophilic factor (recombinant) 250 iu/vial; antihemophilic factor (recombinant) 250 iu/vial